GBNHF vs. MGRX, BRTX, OTRK, AFIB, FNCH, BCEL, NAVB, CLVR, PHAS, and GOVX
Should you be buying Greenbrook TMS stock or one of its competitors? The main competitors of Greenbrook TMS include Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), Ontrak (OTRK), Acutus Medical (AFIB), Finch Therapeutics Group (FNCH), Atreca (BCEL), Navidea Biopharmaceuticals (NAVB), Clever Leaves (CLVR), PhaseBio Pharmaceuticals (PHAS), and GeoVax Labs (GOVX). These companies are all part of the "medical" sector.
Greenbrook TMS (NASDAQ:GBNHF) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.
Greenbrook TMS has a net margin of -66.21% compared to Mangoceuticals' net margin of -1,260.81%. Greenbrook TMS's return on equity of 0.00% beat Mangoceuticals' return on equity.
In the previous week, Mangoceuticals had 1 more articles in the media than Greenbrook TMS. MarketBeat recorded 2 mentions for Mangoceuticals and 1 mentions for Greenbrook TMS. Mangoceuticals' average media sentiment score of 1.43 beat Greenbrook TMS's score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the news media.
Greenbrook TMS and Mangoceuticals both received 0 outperform votes by MarketBeat users.
Mangoceuticals has lower revenue, but higher earnings than Greenbrook TMS.
56.7% of Mangoceuticals shares are owned by institutional investors. 21.7% of Greenbrook TMS shares are owned by insiders. Comparatively, 46.4% of Mangoceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Greenbrook TMS has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.
Summary
Mangoceuticals beats Greenbrook TMS on 6 of the 11 factors compared between the two stocks.
Get Greenbrook TMS News Delivered to You Automatically
Sign up to receive the latest news and ratings for GBNHF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GBNHF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GBNHF vs. The Competition
Greenbrook TMS Competitors List
Related Companies and Tools
